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Abstract
Although various systems have been developed to identify patients
at increased risk of peri- and postoperative mortality and morbidity,
little effort has been made in developing tools to reduce this risk. In
this issue of Critical Care, Pearse et al. publish two reports related
to predicting and improving outcome in high-risk surgical patients.
Rather than conducting large, multicentre, randomised, controlled
trials, the research group at St George’s Hospital in London has
persistently and systematically tested the concept of goal-directed
haemodynamic management in high risk surgery in their single-
centre setting. Their results have been impressive, demonstrating
that in this setting, various outcome measures can be reduced with
goal-directed haemodynamic management. The impressive positive
results of the Pearse studies contrast sharply with the negative
results of multicentre studies, such as that of Sandham et al. One
reason may be that, like several other successful single-centre
trials, Pearse et al. used strict treatment protocols rather than
guidelines. In addition, single-centre studies utilize their investigators’
knowledge of their patients' risk profiles and familiarity with the
care processes and infrastructures of their institutions. An under-
standing of the organisational and case-mix aspects of pre-, peri-
and post-operative management is vital for planning multicentre
trials of goal-directed management.
Risk of death and major complications after surgery is
impressively low today in the general surgical patient
population: less than 1% of all patients undergoing surgery
die during the same hospital admission [1]. Despite this low
overall risk of death, mortality in some subgroups of patients
may be surprisingly high and increases sharply with any
complication necessitating prolonged hospitalisation. For
example, in patients undergoing major abdominal surgery, the
presence of more than one clinical risk factor of surgical
complications may increase the postoperative mortality three-
to four-fold [2]. Similarly, prolongation of hospitalisation after
surgery due to any complication increases the mortality
several fold [1]. It is, therefore, not surprising that various
systems have been developed to identify patients at
increased risk of peri- and postoperative mortality and
morbidity. Examples of such tools include the ASA
classification, the POSSUM scoring system (in diverse
versions), the Shoemaker criteria for high risk, and Goldman’s
cardiac risk index, just to name a few [3-6]. What is much
more surprising is how little effort has been invested in
developing tools to reduce the risk of peri- and postoperative
complications in well-defined patient groups at high risk, and
thus how little success has been achieved in this area.
In this issue of Critical Care, Pearse et al. publish two reports
related to predicting and improving outcome in high-risk
surgical patients [7,8]. In the era of large, multicentre,
randomised, controlled trials, the efforts of the research
group established by Dr David Bennett at St George’s
Hospital, London, represent an alternative approach. Instead
of testing attractive clinical concepts in multicentre,
randomised, controlled trials as soon as possible, these
researchers have been very persistent and systematic in
testing the concept of goal-directed haemodynamic
management in high-risk surgery in their single-centre setting.
They have largely adopted the original strategy presented by
Dr William Shoemaker in the 1980s [5], using predefined
targets of oxygen delivery, first applying the pulmonary artery
catheter and now pulse power/lithium dilution-based cardiac
output monitoring. Dr Bennett’s group started with feasibility
and risk analysis studies, then progressed to randomised,
controlled intervention studies and health economic analyses,
and also applied the results in their daily clinical practice.
The results have been impressive. The St George’s group,
and groups interacting with them, have repeatedly demon-
strated that, in the single-centre setting, various outcome
measures (mortality, morbidity, hospital length of stay and
costs) can be reduced with goal-directed haemodynamic
management. Boyd et al. [9] demonstrated a reduction in
mortality from 23% to 6% with oxygen transport-guided
treatment in patients fulfilling the Shoemaker criteria for high-
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risk surgery in major abdominal surgery. Sinclair et al. [10]
demonstrated reduced morbidity and length of stay in hip
fracture patients when perioperative fluid management was
driven by stroke volume monitoring. Wilson et al. [11]
showed major reductions in mortality and morbidity with peri-
and postoperative oxygen transport-guided treatment in
patients undergoing major abdominal or vascular surgery.
Venn et al. [12] showed reduced length of stay and morbidity
with both central venous pressure- and stroke volume-guided
perioperative treatments in patients with proximal femur
fracture. McKendry et al. [13] showed in cardiac surgery
patients that haemodynamic management driven by stroke
volume postoperatively reduced the length of hospital stay.
The present study by Pearse et al. [7] demonstrates reduced
morbidity and length of hospital stay in high-risk patients
undergoing major, predominantly vascular or abdominal
surgery when receiving oxygen-delivery-driven goal-directed
management based on lithium indicator dilution and pulse
power cardiac output. No difference in mortality was
observed between the goal-directed management and the
control group, and the mortality was substantially lower than
that of the control group in the study by Boyd et al. [9] (15%
versus 23%). Importantly, the management of the control
group was also strictly protocolised, based on central venous
pressure-driven fluid challenges.
This series of single-centre studies with impressive positive
results is in sharp contrast to the negative results of the
multicenter study by Sandham et al. [14], where patients
undergoing major surgery were randomised to receive
pulmonary artery catheter with oxygen transport-driven guide-
lines for peri- and postoperative haemodynamic management
versus conventional management.
What can be the reasons for these major differences? The
major limitations of the Sandham trial have already been
discussed in this journal in detail [15], and will not be repeated
here. Perhaps the most important difference is that all the
successful single-centre trials have used strict treatment
protocols, whereas Sandham et al. used guidelines.
The successful single-centre studies also have to be
interpreted in the context of the specific institutions where
they are performed. The risks associated with surgery are
multifactorial, and the same high-risk criteria applied in
different institutions and to different case mixes may reveal
very different patient profiles. Applying the same high-risk
criteria as Boyd et al. [9] in a multicentre trial, we [2]
observed a mortality of 16% versus the 23% observed by
Boyd et al. Furthermore, patients with only one risk factor had
a mortality of 4%, whereas those with two or more risk factors
had a mortality of 20%.
The single-centre trials utilize their investigators’ intimate
knowledge of the strengths and weaknesses of the care
processes and infrastructures of their institutions, and of the
risk profiles and logistics of the whole production line. These
issues are very difficult to address in a multicentre trial
without far-reaching standardisation. Pre-, peri- and
postoperative management are likely to interact. Does a
postoperative treatment protocol have any chance of
improving outcomes if pre- and perioperative management
have been optimised? Does a perioperative treatment
protocol have any chance if postoperative care is sub-
optimal? How do organisational aspects of postoperative
intermediate and intensive care influence the outcomes?
An understanding of these interactions is vital for planning
multicentre trials of goal-directed management. Without
considering these factors, powerful treatment concepts may
be considered futile, when in fact the cause of futility may lie
elsewhere.
In their second study [8], Pearse et al. show that low
perioperative central venous saturation is associated with an
increased risk of postoperative complications. This finding
should also be viewed in the context of the particular
institution, case mix, and treatment process. Before planning
interventional multicentre trials based on the use of central
venous saturation, it is advisable to ensure that the predictive
value of central venous saturation in the participating centres
and in their case mix remains, and that the patient population
at high risk in those centres can be identified.
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